What It Is
Retatrutide is a novel triple agonist targeting GIP, GLP-1, and glucagon receptors simultaneously. This advanced metabolic peptide coordinates multiple hormonal pathways to create comprehensive metabolic effects superior to dual-agonist compounds.
How It Works
By activating all three receptors, Retatrutide works on multiple metabolic fronts: GLP-1 suppresses appetite and regulates blood sugar, GIP enhances insulin secretion and energy expenditure, and glucagon signalling further boosts metabolic rate. This triple action creates synergistic metabolic effects.
Key Benefits & Use Cases
- Potent appetite suppression through multiple pathways
- Enhanced metabolic rate and energy expenditure
- Improved glucose control and insulin sensitivity
- Comprehensive metabolic support
General Dosage Information
Research protocols typically use 1-2.5mg injected subcutaneously once or twice weekly. The compound has a long half-life supporting less frequent dosing. Always follow your specific research protocol.